Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Novartis
Novartis
Pfizer, Shire, Novartis Alzheimer’s Drugs Win U.K. NICE Backing
Bloomberg
Tue, 01/18/11 - 07:55 am
UK
NICE
Pfizer
Novartis
Shire
Alzheimer's disease
Allergan Sues Novartis Unit Over Patents for Sanctura Medicine
Bloomberg
Thu, 01/13/11 - 01:30 pm
Novartis
lawsuits
Allergan
Sanctura
overactive bladder
6 High Yield Pharmaceutical Companies: Do They Justify the Risk?
Seeking Alpha
Thu, 01/13/11 - 11:57 am
GSK
Bristol-Myers Squibb
Eli Lilly
Merck
Novartis
Pfizer
The FDA approvals of 2010
Fierce Biotech
Wed, 01/12/11 - 07:25 pm
Watson Pharmaceuticals
Theratechnologies
Shire
Savient
Sanofi
Roche
Orphan Europe
Novo Nordisk
Novartis
Merz
JNJ
HRA Pharma
Genzyme
Forest Labs
FDA
Eisai
Dainippon Sumitomo
Chemiche Fabrik Kresussler
Boehringer Ingelheim
Bayer
Auxilium
Amgen
Allergan
Acorda Therapeutics
Here's How Genzyme May Be Failing You
Motley Fool
Tue, 01/11/11 - 02:35 pm
Genzyme
Novartis
AstraZeneca
GSK
Novartis plans trial of equivalent to Roche drug
Marketwatch
Mon, 01/10/11 - 12:16 pm
Roche
Novartis
biosimilars
Rituxan
Sandoz
rheumatoid arthritis
rituximab
Novartis sight drug gets broader EU approval
Reuters
Fri, 01/7/11 - 09:42 am
Novartis
Lucentis
Europe
Novartis, Foundation Medicine in deal
Bizjournals.com
Tue, 01/4/11 - 11:15 am
Novartis
Foundation Medicine
Novartis R&D strategy keeps marketers on the sidelines
Fierce Biotech
Tue, 01/4/11 - 10:07 am
Novartis
R&D
First big pharma Android apps launched
InPharm
Tue, 01/4/11 - 09:59 am
Android
digital pharma
Novartis
Sanofi
2011 Drugmaker M&A Targets
Motley Fool
Fri, 12/31/10 - 10:00 am
M&A
Pfizer
Merck
Genzyme
Sanofi
JNJ
Crucell
ONYX Pharmaceuticals
Bayer
Momenta
Novartis
GSK
Human Genome Sciences
Vertex Pharmaceuticals
MannKind
Vivus
Savient
A Look At The Drug Makers Of 2010
Investopedia
Fri, 12/31/10 - 09:56 am
JNJ
Merck
Novartis
Pfizer
Roche
The Most Promising Dividends in Pharmaceuticals
Motley Fool
Wed, 12/29/10 - 11:48 am
dividends
Eli Lilly
GSK
Bristol-Myers Squibb
Pfizer
Merck
Abbott Laboratories
JNJ
Merdian
Sanofi
Novartis
AstraZeneca
Teva Pharmaceuticals
Novo Nordisk
Teva May Face Copaxone Copy From Novartis, Momenta as Soon as Next Month
Bloomberg
Thu, 12/23/10 - 08:38 am
Teva Pharmaceuticals
Novartis
Copaxone
Momenta
generics
MS
multiple sclerosis
Novartis says FDA cleared new high blood pressure pill combining Tekturna with 2 older drugs
Yahoo/AP
Wed, 12/22/10 - 09:47 pm
FDA
antihypertensives
Tekturna
Novartis
Amtumide
Novartis Pill for Untreatable Multiple Sclerosis Might Reap $5.4 Billion
Bloomberg
Tue, 12/21/10 - 10:48 am
Novartis
MS
multiple sclerosis
Gilenya
Novartis leukemia drug approved in Japan
Marketwatch
Tue, 12/21/10 - 09:59 am
Novartis
leukemia
Tasigna
Japan
The Winner of ASH 2010: Seattle Genetics
Seeking Alpha
Mon, 12/20/10 - 09:59 am
ASH
Seattle Genetics
Celgene
GSK
Immunogen
Micromet
Novartis
Pfizer
YM BioSciences
Sanofi
Bayer, Novartis Vying for Sanofi Animal Health Assets, FTD Says
Bloomberg
Mon, 12/20/10 - 09:54 am
Bayer
Novartis
animal health
Sanofi
Novartis Commits $500 Million to Russia
TheStreet.com
Mon, 12/20/10 - 09:51 am
Russia
Novartis
Pages
« first
‹ previous
…
138
139
140
141
142
143
144
145
146
…
next ›
last »